These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21034367)

  • 1. Transglutaminase: new insights into gelatin nanoparticle cross-linking.
    Fuchs S; Kutscher M; Hertel T; Winter G; Pietzsch M; Coester C
    J Microencapsul; 2010; 27(8):747-54. PubMed ID: 21034367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
    Gaihre B; Khil MS; Lee DR; Kim HY
    Int J Pharm; 2009 Jan; 365(1-2):180-9. PubMed ID: 18790029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production.
    Geh KJ; Hubert M; Winter G
    J Microencapsul; 2016 Nov; 33(7):595-604. PubMed ID: 27556342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of cross-linking parameters during production of transglutaminase-hardened spherical multinuclear microcapsules by complex coacervation.
    Dong ZJ; Xia SQ; Hua S; Hayat K; Zhang XM; Xu SY
    Colloids Surf B Biointerfaces; 2008 May; 63(1):41-7. PubMed ID: 18155888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatin nanoparticle preparation by nanoprecipitation.
    Lee EJ; Khan SA; Lim KH
    J Biomater Sci Polym Ed; 2011; 22(4-6):753-71. PubMed ID: 20566056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
    Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
    Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.
    Azarmi S; Huang Y; Chen H; McQuarrie S; Abrams D; Roa W; Finlay WH; Miller GG; Löbenberg R
    J Pharm Pharm Sci; 2006; 9(1):124-32. PubMed ID: 16849014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions as nanoreactors to produce whey protein nanoparticles with enhanced heat stability by sequential enzymatic cross-linking and thermal pretreatments.
    Zhang W; Zhong Q
    J Agric Food Chem; 2009 Oct; 57(19):9181-9. PubMed ID: 19807163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative reaction mechanism for the cross-linking of gelatin with glutaraldehyde.
    Farris S; Song J; Huang Q
    J Agric Food Chem; 2010 Jan; 58(2):998-1003. PubMed ID: 20043635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical properties of biomimetic tissue adhesive based on the microbial transglutaminase-catalyzed crosslinking of gelatin.
    McDermott MK; Chen T; Williams CM; Markley KM; Payne GF
    Biomacromolecules; 2004; 5(4):1270-9. PubMed ID: 15244440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligent core-shell nanoparticles and hollow spheres based on gelatin and PAA via template polymerization.
    Wang Y; Zhang Y; Du W; Wu C; Zhao J
    J Colloid Interface Sci; 2009 Jun; 334(2):153-60. PubMed ID: 19394956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
    Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
    Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linked polynorbornene-coated gold nanoparticles: dependence of particle stability on cross-linking position and cross-linker structure.
    Liu X; Basu A
    Langmuir; 2008 Oct; 24(19):11169-74. PubMed ID: 18729530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
    Shokry M; Hathout RM; Mansour S
    Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of glutaraldehyde cross-linked vicilin nano- and microparticles.
    Ezpeleta I; Irache JM; Gueguen J; Orecchioni AM
    J Microencapsul; 1997; 14(5):557-65. PubMed ID: 9292432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase-induced or citric acid-mediated cross-linking of whey proteins to tune the characteristics of subsequently desolvated sub-micron and nano-scaled particles.
    Bagheri L; Yarmand M; Madadlou A; Mousavi ME
    J Microencapsul; 2014; 31(7):636-43. PubMed ID: 24766206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Aug; 8(8):758-65. PubMed ID: 18446808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Lactalbumin nanoparticles prepared by desolvation and cross-linking: structure and stability of the assembled protein.
    Arroyo-Maya IJ; Hernández-Sánchez H; Jiménez-Cruz E; Camarillo-Cadena M; Hernández-Arana A
    Biophys Chem; 2014; 193-194():27-34. PubMed ID: 25105879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.